# UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1

> **NIH NIH UG1** · UNIVERSITY OF TX MD ANDERSON CAN CTR · 2022 · $1,911,906

## Abstract

PROJECT SUMMARY
Clinical trials are an integral part of MD Anderson Cancer Center’s (MDACC) mission. In FY2016, we cared for
approximately 135,000 patients and enrolled more than 9,000 patients on nearly 1,000 interventional studies.
MDACC has made significant contributions to the former NCI cooperative groups and the new National Clinical
Trial Network (NCTN), including robust trial enrollment, scientific and administrative leadership, and mentoring
early career faculty to participate in these important national trials. For FY 2014-2017, at MDACC, 858 patients
were enrolled in NCTN Network group clinical trials, including 684 patients in therapeutic treatment trials resulting
in an average of > 215 patients per year. Centralized coordination of NCTN activities at our institution has
facilitated the development and conduct of multidisciplinary, innovative trials. This participation has led to
opportunities for service through various NCTN leadership roles. Our institution has also sponsored talented
clinical and translational investigators to apply for NCTN membership, provided mentorship of early career
faculty, and encouraged applications for NCTN peer-reviewed grant funding. These activities have contributed
to the success of the NCTN LAPS U10 grant as well as working towards the fulfillment of our mission of
eliminating cancer in Texas, nationally, and globally through advances in cancer treatment, research and
education. Our goals will continue with the newly proposed NCTN LAPS UG1 grant.

## Key facts

- **NIH application ID:** 10360511
- **Project number:** 5UG1CA233329-04
- **Recipient organization:** UNIVERSITY OF TX MD ANDERSON CAN CTR
- **Principal Investigator:** KELLY K HUNT
- **Activity code:** UG1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,911,906
- **Award type:** 5
- **Project period:** 2019-03-05 → 2025-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10360511

## Citation

> US National Institutes of Health, RePORTER application 10360511, UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1 (5UG1CA233329-04). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10360511. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*